

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 4.66808074 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.29275896 |
| 3 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.27855704 |
| 4 | heterochromatin organization (GO:0070828) | 4.08086370 |
| 5 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.97612367 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86523028 |
| 7 | positive thymic T cell selection (GO:0045059) | 3.81137371 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76387511 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76387511 |
| 10 | negative regulation of histone methylation (GO:0031061) | 3.72829526 |
| 11 | regulation of RNA export from nucleus (GO:0046831) | 3.69284561 |
| 12 | adherens junction assembly (GO:0034333) | 3.63057520 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56495874 |
| 14 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.56377407 |
| 15 | mRNA stabilization (GO:0048255) | 3.54465406 |
| 16 | RNA stabilization (GO:0043489) | 3.54465406 |
| 17 | regulation of early endosome to late endosome transport (GO:2000641) | 3.53742686 |
| 18 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.53378947 |
| 19 | pre-miRNA processing (GO:0031054) | 3.52712397 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.50976404 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.50976404 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48400607 |
| 23 | positive regulation of protein deacetylation (GO:0090312) | 3.45466790 |
| 24 | peptidyl-lysine dimethylation (GO:0018027) | 3.42266762 |
| 25 | cell-substrate adherens junction assembly (GO:0007045) | 3.36893503 |
| 26 | focal adhesion assembly (GO:0048041) | 3.36893503 |
| 27 | thymic T cell selection (GO:0045061) | 3.31891414 |
| 28 | morphogenesis of an endothelium (GO:0003159) | 3.23856575 |
| 29 | endothelial tube morphogenesis (GO:0061154) | 3.23856575 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23296947 |
| 31 | regulation of histone H3-K9 methylation (GO:0051570) | 3.23267871 |
| 32 | activation of Rac GTPase activity (GO:0032863) | 3.22376218 |
| 33 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.21419398 |
| 34 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.15269299 |
| 35 | maternal placenta development (GO:0001893) | 3.13668443 |
| 36 | mitotic chromosome condensation (GO:0007076) | 3.13110202 |
| 37 | histone H2A monoubiquitination (GO:0035518) | 3.12185277 |
| 38 | modulation by virus of host process (GO:0019054) | 3.11667247 |
| 39 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.09851467 |
| 40 | proline biosynthetic process (GO:0006561) | 3.08455723 |
| 41 | protein localization to endosome (GO:0036010) | 3.07505096 |
| 42 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.05487088 |
| 43 | modulation by symbiont of host cellular process (GO:0044068) | 3.04959069 |
| 44 | chromatin assembly (GO:0031497) | 3.04155545 |
| 45 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.03119841 |
| 46 | viral transcription (GO:0019083) | 3.00776340 |
| 47 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.00220913 |
| 48 | regulation of translational fidelity (GO:0006450) | 2.98986377 |
| 49 | trophectodermal cell differentiation (GO:0001829) | 2.98370679 |
| 50 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.96661599 |
| 51 | activation of MAPKKK activity (GO:0000185) | 2.92266079 |
| 52 | gene silencing (GO:0016458) | 2.90662931 |
| 53 | chromatin silencing (GO:0006342) | 2.88391772 |
| 54 | negative regulation of cell size (GO:0045792) | 2.87454649 |
| 55 | positive T cell selection (GO:0043368) | 2.86573884 |
| 56 | negative regulation of viral release from host cell (GO:1902187) | 2.86167938 |
| 57 | translational termination (GO:0006415) | 2.85315938 |
| 58 | nucleosome disassembly (GO:0006337) | 2.84591352 |
| 59 | protein-DNA complex disassembly (GO:0032986) | 2.84591352 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 2.84272673 |
| 61 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.83403719 |
| 62 | gene silencing by RNA (GO:0031047) | 2.81353067 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79707949 |
| 64 | cellular protein complex localization (GO:0034629) | 2.79610910 |
| 65 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.78595578 |
| 66 | T cell selection (GO:0045058) | 2.78480722 |
| 67 | endothelial cell chemotaxis (GO:0035767) | 2.78006426 |
| 68 | synaptonemal complex assembly (GO:0007130) | 2.77465017 |
| 69 | ncRNA 3-end processing (GO:0043628) | 2.76846966 |
| 70 | protein localization to chromosome, centromeric region (GO:0071459) | 2.76299153 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76155376 |
| 72 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.75792884 |
| 73 | megakaryocyte development (GO:0035855) | 2.74882874 |
| 74 | chromosome condensation (GO:0030261) | 2.74862546 |
| 75 | protein localization to kinetochore (GO:0034501) | 2.74440303 |
| 76 | regulation of integrin activation (GO:0033623) | 2.74282370 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.74157387 |
| 78 | regulation of hippo signaling (GO:0035330) | 2.73606546 |
| 79 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.72175807 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 2.72081124 |
| 81 | mannose metabolic process (GO:0006013) | 2.71309608 |
| 82 | adenosine receptor signaling pathway (GO:0001973) | 2.70118790 |
| 83 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.69118438 |
| 84 | response to peptidoglycan (GO:0032494) | 2.68410138 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.68402159 |
| 86 | regulation of mRNA stability (GO:0043488) | 2.67149408 |
| 87 | mitotic sister chromatid cohesion (GO:0007064) | 2.66892719 |
| 88 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.66676979 |
| 89 | negative T cell selection (GO:0043383) | 2.64641374 |
| 90 | apoptotic process involved in morphogenesis (GO:0060561) | 2.64421521 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.63830181 |
| 92 | glucose catabolic process (GO:0006007) | 2.62885360 |
| 93 | positive regulation of receptor recycling (GO:0001921) | 2.62882596 |
| 94 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.62870536 |
| 95 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.62620533 |
| 96 | cellular response to virus (GO:0098586) | 2.60782325 |
| 97 | nuclear pore complex assembly (GO:0051292) | 2.60448309 |
| 98 | regulation of RNA stability (GO:0043487) | 2.60084094 |
| 99 | positive regulation by host of viral transcription (GO:0043923) | 2.59999110 |
| 100 | cell-substrate junction assembly (GO:0007044) | 2.59543750 |
| 101 | protein complex localization (GO:0031503) | 2.59369836 |
| 102 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.59022260 |
| 103 | natural killer cell differentiation (GO:0001779) | 2.58520493 |
| 104 | negative regulation of histone modification (GO:0031057) | 2.58513797 |
| 105 | ribosomal small subunit assembly (GO:0000028) | 2.57941924 |
| 106 | corticosteroid receptor signaling pathway (GO:0031958) | 2.57782969 |
| 107 | pinocytosis (GO:0006907) | 2.57636548 |
| 108 | translational elongation (GO:0006414) | 2.57600106 |
| 109 | regulation of translational termination (GO:0006449) | 2.57154868 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.54967094 |
| 111 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.54754764 |
| 112 | pentose-phosphate shunt (GO:0006098) | 2.54375591 |
| 113 | negative regulation of RNA splicing (GO:0033119) | 2.54355956 |
| 114 | stress fiber assembly (GO:0043149) | 2.53562243 |
| 115 | synaptonemal complex organization (GO:0070193) | 2.53335995 |
| 116 | COPI coating of Golgi vesicle (GO:0048205) | 2.52575713 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 2.52575713 |
| 118 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50044587 |
| 119 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.49338320 |
| 120 | T cell apoptotic process (GO:0070231) | 2.48098578 |
| 121 | regulation of histone H3-K27 methylation (GO:0061085) | 2.47937284 |
| 122 | maturation of SSU-rRNA (GO:0030490) | 2.47786815 |
| 123 | mitotic G1/S transition checkpoint (GO:0044819) | 2.46738228 |
| 124 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.44949826 |
| 125 | histone H3-K9 demethylation (GO:0033169) | 2.44516718 |
| 126 | lymph vessel development (GO:0001945) | 2.44138938 |
| 127 | embryonic process involved in female pregnancy (GO:0060136) | 2.43070937 |
| 128 | regulation of histone deacetylation (GO:0031063) | 2.42910845 |
| 129 | negative regulation of mRNA metabolic process (GO:1903312) | 2.42598120 |
| 130 | NADPH regeneration (GO:0006740) | 2.42400947 |
| 131 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.41480345 |
| 132 | histone H4-K16 acetylation (GO:0043984) | 2.40476527 |
| 133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.40378372 |
| 134 | epithelial cell-cell adhesion (GO:0090136) | 2.40365726 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39897770 |
| 136 | ribosomal small subunit biogenesis (GO:0042274) | 2.39854127 |
| 137 | modulation by virus of host morphology or physiology (GO:0019048) | 2.39129648 |
| 138 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.38098504 |
| 139 | negative regulation of chromatin modification (GO:1903309) | 2.38055205 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.38008645 |
| 141 | germ cell migration (GO:0008354) | 2.37775382 |
| 142 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.37616592 |
| 143 | regulation of sister chromatid cohesion (GO:0007063) | 2.36458829 |
| 144 | response to UV-C (GO:0010225) | 2.36380763 |
| 145 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.36378477 |
| 146 | mitotic sister chromatid segregation (GO:0000070) | 2.35184702 |
| 147 | cellular response to arsenic-containing substance (GO:0071243) | 2.34859907 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.34160790 |
| 149 | histone H3-K36 demethylation (GO:0070544) | 2.28750867 |
| 150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.27035085 |
| 151 | positive regulation of protein dephosphorylation (GO:0035307) | 2.25687271 |
| 152 | urea cycle (GO:0000050) | 2.23547960 |
| 153 | platelet aggregation (GO:0070527) | 2.23285473 |
| 154 | negative regulation of adherens junction organization (GO:1903392) | 2.22877098 |
| 155 | negative regulation of focal adhesion assembly (GO:0051895) | 2.22877098 |
| 156 | negative regulation of cell junction assembly (GO:1901889) | 2.22877098 |
| 157 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.22404828 |
| 158 | negative regulation of stress fiber assembly (GO:0051497) | 2.20928072 |
| 159 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.19484175 |
| 160 | response to muramyl dipeptide (GO:0032495) | 2.19432792 |
| 161 | activation of JUN kinase activity (GO:0007257) | 2.18684690 |
| 162 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.18684632 |
| 163 | UV protection (GO:0009650) | 2.18601869 |
| 164 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.17297812 |
| 165 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.17297812 |
| 166 | mitochondrial fusion (GO:0008053) | 2.16901875 |
| 167 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.15676664 |
| 168 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.13055160 |
| 169 | regulation of leukocyte degranulation (GO:0043300) | 2.12703930 |
| 170 | modulation by symbiont of host defense response (GO:0052031) | 2.12138181 |
| 171 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12138181 |
| 172 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12138181 |
| 173 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12138181 |
| 174 | modulation by symbiont of host immune response (GO:0052553) | 2.12138181 |
| 175 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12138181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.97847246 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74261825 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.36094997 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82815354 |
| 5 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.70725855 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.63619296 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56243663 |
| 8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33374158 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.31332447 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.30869075 |
| 11 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.30727329 |
| 12 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06257316 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03241210 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02450601 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01002966 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00014434 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99930145 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99129527 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.96962408 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84565995 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80097610 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75934069 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73021820 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72225355 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67847442 |
| 26 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.67688694 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67132110 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66289884 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63621584 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61094886 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60612107 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.57715904 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.56571813 |
| 34 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55889010 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54539277 |
| 36 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52540999 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51228090 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50125424 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49299574 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.47860744 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44200251 |
| 42 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.43460994 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43358892 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42780438 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42183427 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41612295 |
| 47 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.40878659 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40853406 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39759867 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39093659 |
| 51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38933025 |
| 52 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36220049 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34393728 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30958163 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30645867 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30557200 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30350294 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29754078 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27622428 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27354718 |
| 61 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.25963042 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23577312 |
| 63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23354405 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21638272 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21366584 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20865419 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19016623 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17860567 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16624847 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16517668 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15575426 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.15099628 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13580855 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13345672 |
| 75 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13097731 |
| 76 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13080147 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12518747 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10828028 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10372043 |
| 80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.10344012 |
| 81 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10029196 |
| 82 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09169696 |
| 83 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08824440 |
| 84 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08538412 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07925428 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07630365 |
| 87 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.07387483 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06466458 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04962466 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04061113 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03600613 |
| 92 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03537368 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02918390 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02694676 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02675206 |
| 96 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01764643 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01183627 |
| 98 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00450865 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00377155 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99876597 |
| 101 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99759136 |
| 102 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99679123 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99111108 |
| 104 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98480375 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98066785 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97999238 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97753985 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97597623 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97560374 |
| 110 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97350170 |
| 111 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97262540 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96701558 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96475524 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96348084 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95205013 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94177492 |
| 117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94043069 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93845128 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92587515 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92445032 |
| 121 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90854768 |
| 122 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88995101 |
| 123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88332804 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87324969 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87051169 |
| 126 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86801100 |
| 127 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.86737434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 2.86523513 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.73299406 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.70019273 |
| 4 | MP0005451_abnormal_body_composition | 2.69793454 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.43915333 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.42016596 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.41456527 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.34165050 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.22999137 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.21824217 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.21824217 |
| 12 | MP0009840_abnormal_foam_cell | 2.17296765 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.14857398 |
| 14 | MP0008260_abnormal_autophagy | 2.12253104 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 2.08941049 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.08594077 |
| 17 | MP0003303_peritoneal_inflammation | 2.00108751 |
| 18 | MP0000685_abnormal_immune_system | 1.91314844 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 1.82069788 |
| 20 | MP0005623_abnormal_meninges_morphology | 1.80889873 |
| 21 | MP0002653_abnormal_ependyma_morphology | 1.78433156 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.77731206 |
| 23 | MP0001849_ear_inflammation | 1.77572120 |
| 24 | MP0003111_abnormal_nucleus_morphology | 1.75943429 |
| 25 | MP0001730_embryonic_growth_arrest | 1.75401487 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.72442110 |
| 27 | MP0002398_abnormal_bone_marrow | 1.71098431 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.69068003 |
| 29 | MP0004510_myositis | 1.67275359 |
| 30 | MP0003077_abnormal_cell_cycle | 1.67265259 |
| 31 | MP0008057_abnormal_DNA_replication | 1.64501951 |
| 32 | MP0002796_impaired_skin_barrier | 1.59443104 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.58810398 |
| 34 | MP0000858_altered_metastatic_potential | 1.57142819 |
| 35 | MP0005501_abnormal_skin_physiology | 1.57091394 |
| 36 | MP0003091_abnormal_cell_migration | 1.56395361 |
| 37 | MP0002249_abnormal_larynx_morphology | 1.54615444 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.53907782 |
| 39 | MP0001800_abnormal_humoral_immune | 1.53467575 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.51190129 |
| 41 | MP0002722_abnormal_immune_system | 1.50240595 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.49275988 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.48768199 |
| 44 | MP0010307_abnormal_tumor_latency | 1.48314374 |
| 45 | MP0002405_respiratory_system_inflammati | 1.47759501 |
| 46 | MP0004233_abnormal_muscle_weight | 1.47227352 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.40539745 |
| 48 | MP0005410_abnormal_fertilization | 1.40525936 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.37942997 |
| 50 | MP0003984_embryonic_growth_retardation | 1.36704846 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.34111336 |
| 52 | MP0005380_embryogenesis_phenotype | 1.33481832 |
| 53 | MP0001672_abnormal_embryogenesis/_devel | 1.33481832 |
| 54 | MP0002086_abnormal_extraembryonic_tissu | 1.31772704 |
| 55 | MP0000609_abnormal_liver_physiology | 1.28842026 |
| 56 | MP0000716_abnormal_immune_system | 1.27578253 |
| 57 | MP0004858_abnormal_nervous_system | 1.26790081 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.26371826 |
| 59 | MP0005360_urolithiasis | 1.25795331 |
| 60 | MP0004381_abnormal_hair_follicle | 1.25223766 |
| 61 | MP0005083_abnormal_biliary_tract | 1.23637873 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.23328457 |
| 63 | MP0001697_abnormal_embryo_size | 1.23284519 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.22763984 |
| 65 | MP0001929_abnormal_gametogenesis | 1.22301519 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.21958921 |
| 67 | MP0002429_abnormal_blood_cell | 1.21496631 |
| 68 | MP0005409_darkened_coat_color | 1.21344378 |
| 69 | MP0002084_abnormal_developmental_patter | 1.20716410 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.20270925 |
| 71 | MP0000733_abnormal_muscle_development | 1.17590214 |
| 72 | MP0010094_abnormal_chromosome_stability | 1.17400574 |
| 73 | MP0000490_abnormal_crypts_of | 1.17188747 |
| 74 | MP0001348_abnormal_lacrimal_gland | 1.15709281 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.14614054 |
| 76 | MP0002080_prenatal_lethality | 1.14513993 |
| 77 | MP0009053_abnormal_anal_canal | 1.14340725 |
| 78 | MP0005387_immune_system_phenotype | 1.13764521 |
| 79 | MP0001790_abnormal_immune_system | 1.13764521 |
| 80 | MP0003828_pulmonary_edema | 1.12979913 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.11574726 |
| 82 | MP0005621_abnormal_cell_physiology | 1.11386568 |
| 83 | MP0002723_abnormal_immune_serum | 1.11109463 |
| 84 | MP0002420_abnormal_adaptive_immunity | 1.11056351 |
| 85 | MP0001873_stomach_inflammation | 1.10078191 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.10045650 |
| 87 | MP0010630_abnormal_cardiac_muscle | 1.08679927 |
| 88 | MP0002085_abnormal_embryonic_tissue | 1.08403347 |
| 89 | MP0001819_abnormal_immune_cell | 1.07665141 |
| 90 | MP0002452_abnormal_antigen_presenting | 1.06926177 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.06057943 |
| 92 | MP0003172_abnormal_lysosome_physiology | 1.05834590 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.05235045 |
| 94 | MP0005365_abnormal_bile_salt | 1.04867415 |
| 95 | MP0005375_adipose_tissue_phenotype | 1.04659154 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 1.03745216 |
| 97 | MP0004947_skin_inflammation | 1.02553258 |
| 98 | MP0000313_abnormal_cell_death | 1.02048799 |
| 99 | MP0008877_abnormal_DNA_methylation | 1.01661610 |
| 100 | MP0000537_abnormal_urethra_morphology | 1.01142267 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.99620258 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.99573644 |
| 103 | MP0010030_abnormal_orbit_morphology | 0.99394565 |
| 104 | MP0005670_abnormal_white_adipose | 0.98755685 |
| 105 | MP0001835_abnormal_antigen_presentation | 0.97386196 |
| 106 | MP0002419_abnormal_innate_immunity | 0.96522241 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.95208622 |
| 108 | MP0003866_abnormal_defecation | 0.94776725 |
| 109 | MP0008004_abnormal_stomach_pH | 0.94363673 |
| 110 | MP0008770_decreased_survivor_rate | 0.94158346 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.92354815 |
| 112 | MP0000598_abnormal_liver_morphology | 0.92104635 |
| 113 | MP0003646_muscle_fatigue | 0.91901566 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.91301687 |
| 115 | MP0005025_abnormal_response_to | 0.91219826 |
| 116 | MP0009931_abnormal_skin_appearance | 0.89970404 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.89924103 |
| 118 | MP0001915_intracranial_hemorrhage | 0.89460198 |
| 119 | MP0008932_abnormal_embryonic_tissue | 0.89460131 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.89208244 |
| 121 | MP0002132_abnormal_respiratory_system | 0.89165579 |
| 122 | MP0004084_abnormal_cardiac_muscle | 0.89149441 |
| 123 | MP0001851_eye_inflammation | 0.88923207 |
| 124 | MP0002210_abnormal_sex_determination | 0.88676285 |
| 125 | MP0008995_early_reproductive_senescence | 0.87199858 |
| 126 | MP0002060_abnormal_skin_morphology | 0.86547021 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.85877497 |
| 128 | MP0002925_abnormal_cardiovascular_devel | 0.85811034 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.84587789 |
| 130 | MP0009672_abnormal_birth_weight | 0.84013289 |
| 131 | MP0002009_preneoplasia | 0.83771262 |
| 132 | MP0001145_abnormal_male_reproductive | 0.82857783 |
| 133 | MP0005023_abnormal_wound_healing | 0.82626942 |
| 134 | MP0005671_abnormal_response_to | 0.80735770 |
| 135 | MP0003436_decreased_susceptibility_to | 0.79276663 |
| 136 | MP0003698_abnormal_male_reproductive | 0.77426165 |
| 137 | MP0010329_abnormal_lipoprotein_level | 0.77301727 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.76724249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 4.86890522 |
| 2 | Abnormality of the nasal mucosa (HP:0000433) | 4.53808499 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.93468260 |
| 4 | Purpura (HP:0000979) | 3.38132790 |
| 5 | Polycythemia (HP:0001901) | 3.12662941 |
| 6 | Basal cell carcinoma (HP:0002671) | 3.12020963 |
| 7 | Male infertility (HP:0003251) | 3.04457906 |
| 8 | Menorrhagia (HP:0000132) | 2.83096489 |
| 9 | Hyperacusis (HP:0010780) | 2.78531996 |
| 10 | Colitis (HP:0002583) | 2.77751755 |
| 11 | Abnormal platelet function (HP:0011869) | 2.76017967 |
| 12 | Impaired platelet aggregation (HP:0003540) | 2.76017967 |
| 13 | Verrucae (HP:0200043) | 2.69221879 |
| 14 | Papilloma (HP:0012740) | 2.69221879 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.62477388 |
| 16 | Gastrointestinal inflammation (HP:0004386) | 2.61580323 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 2.59871741 |
| 18 | Multiple enchondromatosis (HP:0005701) | 2.57995464 |
| 19 | Recurrent bronchitis (HP:0002837) | 2.57802226 |
| 20 | Obstructive sleep apnea (HP:0002870) | 2.57142471 |
| 21 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.55302910 |
| 22 | Distal lower limb amyotrophy (HP:0008944) | 2.55033456 |
| 23 | Progressive muscle weakness (HP:0003323) | 2.52484755 |
| 24 | Heterotopia (HP:0002282) | 2.52119693 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.46906103 |
| 26 | Increased density of long bones (HP:0006392) | 2.45679877 |
| 27 | Ulnar bowing (HP:0003031) | 2.44398438 |
| 28 | Broad distal phalanx of finger (HP:0009836) | 2.44203676 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.41863807 |
| 30 | Thrombocytosis (HP:0001894) | 2.41145053 |
| 31 | T lymphocytopenia (HP:0005403) | 2.39860055 |
| 32 | Septate vagina (HP:0001153) | 2.39786844 |
| 33 | Prominent nose (HP:0000448) | 2.39290084 |
| 34 | Fatigue (HP:0012378) | 2.38383972 |
| 35 | Ependymoma (HP:0002888) | 2.35211113 |
| 36 | Inflammation of the large intestine (HP:0002037) | 2.34415739 |
| 37 | Squamous cell carcinoma (HP:0002860) | 2.33746809 |
| 38 | Macroorchidism (HP:0000053) | 2.30045932 |
| 39 | Broad face (HP:0000283) | 2.28543752 |
| 40 | Pseudobulbar signs (HP:0002200) | 2.25303230 |
| 41 | Hypercortisolism (HP:0001578) | 2.23320198 |
| 42 | Petechiae (HP:0000967) | 2.22935547 |
| 43 | Increased connective tissue (HP:0009025) | 2.22117185 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.22099349 |
| 45 | Bronchitis (HP:0012387) | 2.20516656 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20020594 |
| 47 | IgM deficiency (HP:0002850) | 2.19381259 |
| 48 | Hyperparathyroidism (HP:0000843) | 2.18073668 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.18068364 |
| 50 | Mitral valve prolapse (HP:0001634) | 2.16876904 |
| 51 | Deep palmar crease (HP:0006191) | 2.16511693 |
| 52 | Rectal prolapse (HP:0002035) | 2.15985778 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.14611414 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.13945773 |
| 55 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.13548196 |
| 56 | Thin bony cortex (HP:0002753) | 2.13265679 |
| 57 | Recurrent viral infections (HP:0004429) | 2.10266509 |
| 58 | Progressive external ophthalmoplegia (HP:0000590) | 2.07766009 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07476068 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.06598868 |
| 61 | Trismus (HP:0000211) | 2.06426708 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.05697159 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04594293 |
| 64 | Disproportionate tall stature (HP:0001519) | 2.04572508 |
| 65 | Long palpebral fissure (HP:0000637) | 2.03755414 |
| 66 | Persistence of primary teeth (HP:0006335) | 2.03356878 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.02178281 |
| 68 | Cholecystitis (HP:0001082) | 2.02178281 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.01346598 |
| 70 | Achilles tendon contracture (HP:0001771) | 2.01296323 |
| 71 | Hand muscle atrophy (HP:0009130) | 2.00508241 |
| 72 | Distal upper limb amyotrophy (HP:0007149) | 2.00477054 |
| 73 | Upper limb amyotrophy (HP:0009129) | 2.00477054 |
| 74 | Ragged-red muscle fibers (HP:0003200) | 2.00325722 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.00154348 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99935335 |
| 77 | Chronic otitis media (HP:0000389) | 1.97786924 |
| 78 | Increased mean platelet volume (HP:0011877) | 1.96882644 |
| 79 | Deep venous thrombosis (HP:0002625) | 1.96340421 |
| 80 | Asymmetry of the thorax (HP:0001555) | 1.95635211 |
| 81 | Hematochezia (HP:0002573) | 1.95611965 |
| 82 | High pitched voice (HP:0001620) | 1.95182928 |
| 83 | Infertility (HP:0000789) | 1.94727847 |
| 84 | Increased serum ferritin (HP:0003281) | 1.93617133 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 1.93358024 |
| 86 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.93169664 |
| 87 | Neoplasm of striated muscle (HP:0009728) | 1.92932238 |
| 88 | Atrioventricular block (HP:0001678) | 1.92312356 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 1.92081200 |
| 90 | Cellulitis (HP:0100658) | 1.92066968 |
| 91 | Aneurysm (HP:0002617) | 1.91585979 |
| 92 | Cutaneous melanoma (HP:0012056) | 1.91439210 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 1.90885001 |
| 94 | Sparse lateral eyebrow (HP:0005338) | 1.90732694 |
| 95 | Flat acetabular roof (HP:0003180) | 1.90688243 |
| 96 | Abnormality of T cells (HP:0002843) | 1.89495482 |
| 97 | Recurrent sinusitis (HP:0011108) | 1.88781192 |
| 98 | Global brain atrophy (HP:0002283) | 1.88522748 |
| 99 | Dysmetric saccades (HP:0000641) | 1.87943006 |
| 100 | Bronchiectasis (HP:0002110) | 1.87334474 |
| 101 | Genu recurvatum (HP:0002816) | 1.87034439 |
| 102 | Ankyloglossia (HP:0010296) | 1.86567368 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 1.86300371 |
| 104 | Back pain (HP:0003418) | 1.85841509 |
| 105 | Abnormal large intestine physiology (HP:0012700) | 1.84320981 |
| 106 | Recurrent otitis media (HP:0000403) | 1.83597088 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 1.82890073 |
| 108 | Insomnia (HP:0100785) | 1.82184572 |
| 109 | Long eyelashes (HP:0000527) | 1.81063462 |
| 110 | Selective tooth agenesis (HP:0001592) | 1.80527999 |
| 111 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.80485506 |
| 112 | Short 4th metacarpal (HP:0010044) | 1.80485506 |
| 113 | Skin tags (HP:0010609) | 1.80170666 |
| 114 | Recurrent abscess formation (HP:0002722) | 1.79960514 |
| 115 | Facial hemangioma (HP:0000329) | 1.79722163 |
| 116 | Hypertensive crisis (HP:0100735) | 1.79067418 |
| 117 | Breast hypoplasia (HP:0003187) | 1.78657732 |
| 118 | Reticulocytosis (HP:0001923) | 1.77226967 |
| 119 | Rhabdomyosarcoma (HP:0002859) | 1.75625569 |
| 120 | Dysostosis multiplex (HP:0000943) | 1.74200186 |
| 121 | Truncus arteriosus (HP:0001660) | 1.74084759 |
| 122 | Epistaxis (HP:0000421) | 1.74023128 |
| 123 | Enlarged penis (HP:0000040) | 1.73300754 |
| 124 | Hypochromic anemia (HP:0001931) | 1.73295153 |
| 125 | Bowel incontinence (HP:0002607) | 1.73290536 |
| 126 | Abnormality of the 4th metacarpal (HP:0010012) | 1.73268773 |
| 127 | Impulsivity (HP:0100710) | 1.73153695 |
| 128 | Spinal cord lesions (HP:0100561) | 1.72551681 |
| 129 | Syringomyelia (HP:0003396) | 1.72551681 |
| 130 | Increased cerebral lipofuscin (HP:0011813) | 1.72483528 |
| 131 | Fibroma (HP:0010614) | 1.71315142 |
| 132 | Chest pain (HP:0100749) | 1.71170652 |
| 133 | Pustule (HP:0200039) | 1.70708841 |
| 134 | Renal cell carcinoma (HP:0005584) | 1.70521785 |
| 135 | Hyperthyroidism (HP:0000836) | 1.69323036 |
| 136 | Polygenic inheritance (HP:0010982) | 1.69310026 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.68266065 |
| 138 | Dislocated radial head (HP:0003083) | 1.67877019 |
| 139 | Medulloblastoma (HP:0002885) | 1.67776137 |
| 140 | Uterine leiomyosarcoma (HP:0002891) | 1.67241067 |
| 141 | Leiomyosarcoma (HP:0100243) | 1.67241067 |
| 142 | Recurrent bacterial skin infections (HP:0005406) | 1.67150001 |
| 143 | Gout (HP:0001997) | 1.67023401 |
| 144 | Increased nuchal translucency (HP:0010880) | 1.66999947 |
| 145 | Neoplasm of the oral cavity (HP:0100649) | 1.66624163 |
| 146 | Recurrent fungal infections (HP:0002841) | 1.66001497 |
| 147 | Cafe-au-lait spot (HP:0000957) | 1.65911936 |
| 148 | Malnutrition (HP:0004395) | 1.65881442 |
| 149 | Angiofibromas (HP:0010615) | 1.65777349 |
| 150 | Adenoma sebaceum (HP:0009720) | 1.65777349 |
| 151 | Bicuspid aortic valve (HP:0001647) | 1.65370684 |
| 152 | Bone pain (HP:0002653) | 1.64787068 |
| 153 | Chronic bronchitis (HP:0004469) | 1.64588300 |
| 154 | Emphysema (HP:0002097) | 1.64258450 |
| 155 | Overlapping toe (HP:0001845) | 1.63359434 |
| 156 | Increased variability in muscle fiber diameter (HP:0003557) | 1.63186922 |
| 157 | Premature skin wrinkling (HP:0100678) | 1.63052130 |
| 158 | Amaurosis fugax (HP:0100576) | 1.63007099 |
| 159 | Chronic obstructive pulmonary disease (HP:0006510) | 1.62932527 |
| 160 | Obstructive lung disease (HP:0006536) | 1.62932527 |
| 161 | Ankle contracture (HP:0006466) | 1.62759045 |
| 162 | Annular pancreas (HP:0001734) | 1.62668673 |
| 163 | Protrusio acetabuli (HP:0003179) | 1.62667958 |
| 164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62600522 |
| 165 | Abnormality of oral frenula (HP:0000190) | 1.60777591 |
| 166 | Difficulty climbing stairs (HP:0003551) | 1.60729363 |
| 167 | Loss of speech (HP:0002371) | 1.58555301 |
| 168 | Abnormality of the umbilical cord (HP:0010881) | 1.58529081 |
| 169 | Spinal cord compression (HP:0002176) | 1.57423416 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.56946371 |
| 171 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.56489454 |
| 172 | Hypertriglyceridemia (HP:0002155) | 1.56387191 |
| 173 | Mitral regurgitation (HP:0001653) | 1.56384260 |
| 174 | Patellar dislocation (HP:0002999) | 1.56355840 |
| 175 | Abnormality of the radial head (HP:0003995) | 1.55850467 |
| 176 | Abnormal ossification of hand bones (HP:0005921) | 1.55271485 |
| 177 | Lower limb amyotrophy (HP:0007210) | 1.54338080 |
| 178 | Pointed chin (HP:0000307) | 1.53317105 |
| 179 | Hepatosplenomegaly (HP:0001433) | 1.53184558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.32335527 |
| 2 | SMG1 | 4.08802493 |
| 3 | TRIB3 | 3.99881590 |
| 4 | CDK12 | 3.70555702 |
| 5 | PRPF4B | 3.22092783 |
| 6 | IRAK3 | 3.21247078 |
| 7 | MAP4K1 | 3.17977438 |
| 8 | PKN2 | 3.06973565 |
| 9 | MAP3K10 | 2.88441351 |
| 10 | ICK | 2.72381425 |
| 11 | NME2 | 2.31791379 |
| 12 | NEK2 | 2.23912323 |
| 13 | GRK6 | 2.09681536 |
| 14 | RIPK4 | 1.95330886 |
| 15 | ERN1 | 1.87679500 |
| 16 | STK10 | 1.82753402 |
| 17 | TAOK1 | 1.64388123 |
| 18 | TAOK2 | 1.61052344 |
| 19 | PRKD3 | 1.54782924 |
| 20 | CDC7 | 1.52406295 |
| 21 | TYK2 | 1.34587858 |
| 22 | MAP3K3 | 1.34042973 |
| 23 | TYRO3 | 1.31782689 |
| 24 | CDK4 | 1.30402492 |
| 25 | LRRK2 | 1.29911116 |
| 26 | TAOK3 | 1.29240887 |
| 27 | PTK6 | 1.24584499 |
| 28 | TESK2 | 1.23028911 |
| 29 | PRKD2 | 1.22866995 |
| 30 | EPHA2 | 1.22017248 |
| 31 | ZAP70 | 1.21954794 |
| 32 | TTN | 1.19423405 |
| 33 | IRAK4 | 1.15892622 |
| 34 | ARAF | 1.12152223 |
| 35 | IRAK2 | 1.11869045 |
| 36 | MTOR | 1.11512494 |
| 37 | ALK | 1.11154617 |
| 38 | BRD4 | 1.09986112 |
| 39 | MAP2K2 | 1.05130278 |
| 40 | TGFBR2 | 1.02243801 |
| 41 | STK3 | 1.02235214 |
| 42 | PAK4 | 1.02213493 |
| 43 | RPS6KB2 | 1.00273164 |
| 44 | CDK7 | 1.00032944 |
| 45 | EPHB1 | 0.99494809 |
| 46 | SIK1 | 0.99400544 |
| 47 | PDGFRA | 0.97926693 |
| 48 | MAP3K6 | 0.96617061 |
| 49 | FGFR4 | 0.96117990 |
| 50 | HIPK2 | 0.95973957 |
| 51 | MAP2K3 | 0.95890305 |
| 52 | PIM1 | 0.95862398 |
| 53 | PDK4 | 0.95048386 |
| 54 | PDK3 | 0.95048386 |
| 55 | BMX | 0.94050798 |
| 56 | LATS1 | 0.91658352 |
| 57 | RIPK1 | 0.89338543 |
| 58 | CDK6 | 0.88345591 |
| 59 | CDC42BPA | 0.88149491 |
| 60 | PDGFRB | 0.87051013 |
| 61 | RPS6KA4 | 0.86620072 |
| 62 | MAP3K7 | 0.85507320 |
| 63 | PIM2 | 0.84194595 |
| 64 | MAP3K8 | 0.83373910 |
| 65 | KSR2 | 0.83298018 |
| 66 | CDK9 | 0.81916416 |
| 67 | MARK3 | 0.80581811 |
| 68 | BTK | 0.80513008 |
| 69 | CSF1R | 0.80467244 |
| 70 | ITK | 0.80403588 |
| 71 | AURKA | 0.80293081 |
| 72 | FLT3 | 0.80127700 |
| 73 | JAK3 | 0.79498431 |
| 74 | SIK2 | 0.79025047 |
| 75 | BRAF | 0.78363631 |
| 76 | MST1R | 0.77878840 |
| 77 | JAK1 | 0.77098769 |
| 78 | MAP3K14 | 0.76903754 |
| 79 | HCK | 0.75992113 |
| 80 | NLK | 0.75290354 |
| 81 | CAMK1D | 0.71301630 |
| 82 | MAP3K11 | 0.70408221 |
| 83 | MARK2 | 0.70311288 |
| 84 | DYRK3 | 0.68542602 |
| 85 | PDK1 | 0.66586902 |
| 86 | SIK3 | 0.66309982 |
| 87 | LATS2 | 0.66177145 |
| 88 | PRKCH | 0.64809104 |
| 89 | STK4 | 0.64679832 |
| 90 | ILK | 0.64678479 |
| 91 | BUB1 | 0.64314590 |
| 92 | RPS6KL1 | 0.64245085 |
| 93 | RPS6KC1 | 0.64245085 |
| 94 | MAPKAPK3 | 0.64067870 |
| 95 | TNK2 | 0.63742320 |
| 96 | CAMK1G | 0.63120986 |
| 97 | CSK | 0.63098548 |
| 98 | TTK | 0.62705731 |
| 99 | MELK | 0.61810437 |
| 100 | MAPK11 | 0.61276784 |
| 101 | RPS6KA2 | 0.61045416 |
| 102 | PAK2 | 0.60406338 |
| 103 | JAK2 | 0.60361953 |
| 104 | RET | 0.59655289 |
| 105 | KIT | 0.58760181 |
| 106 | FGFR3 | 0.56560783 |
| 107 | LMTK2 | 0.56189633 |
| 108 | PASK | 0.55214796 |
| 109 | SCYL2 | 0.54468928 |
| 110 | CHUK | 0.53827303 |
| 111 | IKBKB | 0.53763781 |
| 112 | PAK1 | 0.53586432 |
| 113 | BLK | 0.51085960 |
| 114 | CHEK1 | 0.50624769 |
| 115 | RAF1 | 0.49567675 |
| 116 | PDPK1 | 0.49530653 |
| 117 | LCK | 0.49145942 |
| 118 | MAPK12 | 0.47502723 |
| 119 | MATK | 0.47467897 |
| 120 | DYRK1B | 0.47466261 |
| 121 | MAP3K9 | 0.45230357 |
| 122 | RPS6KA1 | 0.44665302 |
| 123 | TBK1 | 0.44214851 |
| 124 | EIF2AK1 | 0.43804345 |
| 125 | CDK2 | 0.43553002 |
| 126 | PTK2 | 0.43207544 |
| 127 | MAP3K13 | 0.43163620 |
| 128 | CHEK2 | 0.43122240 |
| 129 | STK38 | 0.43000131 |
| 130 | AKT2 | 0.42007995 |
| 131 | MAPKAPK2 | 0.41354613 |
| 132 | PRKD1 | 0.40429539 |
| 133 | RPS6KA6 | 0.39472547 |
| 134 | DMPK | 0.39443867 |
| 135 | TESK1 | 0.39313006 |
| 136 | STK11 | 0.37955362 |
| 137 | TGFBR1 | 0.37444581 |
| 138 | BCKDK | 0.36941369 |
| 139 | PRKAA1 | 0.36559710 |
| 140 | MAP3K1 | 0.36309241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.28743626 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.05575167 |
| 3 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.02334195 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98491129 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.95710140 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89564881 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.77815254 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76808538 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.75478304 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72948117 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68138802 |
| 12 | Insulin resistance_Homo sapiens_hsa04931 | 1.59251188 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53001295 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.48944044 |
| 15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48237296 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48091047 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.48059674 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46076926 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44394581 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35164798 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34855348 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34723382 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.32363750 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29458738 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.29424053 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29151364 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27871996 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.27448576 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.27189359 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.26186191 |
| 31 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24862713 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24719062 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23568178 |
| 34 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.20262375 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19136213 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.19031584 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18687761 |
| 38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15542466 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.14925045 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.13219733 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12772730 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.11984187 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11469124 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.10982726 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09487659 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.08695480 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.08590301 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08227905 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04652402 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04118608 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03868075 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02026949 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.01850568 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99100445 |
| 55 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98868328 |
| 56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.98405790 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98263755 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98176972 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96671075 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95129174 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94485677 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93998319 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91981389 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.91679076 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91346143 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90108419 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.89384231 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89271056 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.88199164 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87341388 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86589719 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85984638 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.85212063 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84755413 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84349490 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83941320 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83926014 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.83860134 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82738322 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82688095 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.82314476 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82188104 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82033996 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.80546576 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80259986 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80135103 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79574913 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79003303 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77543435 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76656794 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76101743 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74312902 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73824585 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73368387 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72800649 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.69925624 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69288786 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68674562 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68388099 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67746789 |
| 101 | Tuberculosis_Homo sapiens_hsa05152 | 0.66336213 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.66204167 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.64832910 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.64762468 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64110468 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63046023 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.62719216 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.62074752 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.60672341 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.60545599 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59667544 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59554349 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59490444 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58729970 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57904279 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.57209859 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56854077 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.55686347 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55018525 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54311780 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.53861650 |
| 122 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53633807 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53005156 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52716704 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52680592 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52289322 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51181716 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50964398 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50759020 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50734008 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50255966 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49577330 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48602215 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.48565752 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48077662 |

